293 related articles for article (PubMed ID: 16405939)
1. CYP1A2 and NAT2 phenotyping and 3-aminobiphenyl and 4-aminobiphenyl hemoglobin adduct levels in smokers and non-smokers.
Sarkar M; Stabbert R; Kinser RD; Oey J; Rustemeier K; von Holt K; Schepers G; Walk RA; Roethig HJ
Toxicol Appl Pharmacol; 2006 Jun; 213(3):198-206. PubMed ID: 16405939
[TBL] [Abstract][Full Text] [Related]
2. Cytochrome P4501A2: enzyme induction and genetic control in determining 4-aminobiphenyl-hemoglobin adduct levels.
Landi MT; Zocchetti C; Bernucci I; Kadlubar FF; Tannenbaum S; Skipper P; Bartsch H; Malaveille C; Shields P; Caporaso NE; Vineis P
Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):693-8. PubMed ID: 8877060
[TBL] [Abstract][Full Text] [Related]
3. N-acetyltransferase 2 phenotype but not NAT1*10 genotype affects aminobiphenyl-hemoglobin adduct levels.
Probst-Hensch NM; Bell DA; Watson MA; Skipper PL; Tannenbaum SR; Chan KK; Ross RK; Yu MC
Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):619-23. PubMed ID: 10868698
[TBL] [Abstract][Full Text] [Related]
4. Biomonitoring of smoke constituents: exposure to 4-aminobiphenyl and 4-aminobiphenyl hemoglobin adduct levels in nonsmokers and smokers.
Schorp MK; Leyden DE
Inhal Toxicol; 2010 Aug; 22(9):725-37. PubMed ID: 20433335
[TBL] [Abstract][Full Text] [Related]
5. The use of 4-aminobiphenyl hemoglobin adducts and aromatic DNA adducts in lymphocytes of smokers as biomarkers of exposure.
Dallinga JW; Pachen DM; Wijnhoven SW; Breedijk A; van 't Veer L; Wigbout G; van Zandwijk N; Maas LM; van Agen E; Kleinjans JC; van Schooten FJ
Cancer Epidemiol Biomarkers Prev; 1998 Jul; 7(7):571-7. PubMed ID: 9681524
[TBL] [Abstract][Full Text] [Related]
6. Environmental tobacco smoke and bladder cancer risk in never smokers of Los Angeles County.
Jiang X; Yuan JM; Skipper PL; Tannenbaum SR; Yu MC
Cancer Res; 2007 Aug; 67(15):7540-5. PubMed ID: 17671226
[TBL] [Abstract][Full Text] [Related]
7. DNA adducts, protein adducts, and sister chromatid exchange in cigarette smokers and nonsmokers.
Perera FP; Santella RM; Brenner D; Poirier MC; Munshi AA; Fischman HK; Van Ryzin J
J Natl Cancer Inst; 1987 Sep; 79(3):449-56. PubMed ID: 3114532
[TBL] [Abstract][Full Text] [Related]
8. Potential role of cytochrome P450-1B1 in the metabolic activation of 4-aminobiphenyl in humans.
Ketelslegers HB; Godschalk RW; Eskens BJ; Dallinga JW; Gottschalk RW; van Schooten FJ; van Delft JH; Kleinjans JC
Mol Carcinog; 2009 Aug; 48(8):685-91. PubMed ID: 19274671
[TBL] [Abstract][Full Text] [Related]
9. Frequency of urination and its effects on metabolism, pharmacokinetics, blood hemoglobin adduct formation, and liver and urinary bladder DNA adduct levels in beagle dogs given the carcinogen 4-aminobiphenyl.
Kadlubar FF; Dooley KL; Teitel CH; Roberts DW; Benson RW; Butler MA; Bailey JR; Young JF; Skipper PW; Tannenbaum SR
Cancer Res; 1991 Aug; 51(16):4371-7. PubMed ID: 1868460
[TBL] [Abstract][Full Text] [Related]
10. Haemoglobin adducts of aromatic amines in people exposed to cigarette smoke.
Bryant MS; Vineis P; Skipper PL; Tannenbaum SR
IARC Sci Publ; 1988; (89):133-6. PubMed ID: 3198197
[TBL] [Abstract][Full Text] [Related]
11. Hemoglobin adducts of 4-aminobiphenyl in smokers and nonsmokers.
Bryant MS; Skipper PL; Tannenbaum SR; Maclure M
Cancer Res; 1987 Jan; 47(2):602-8. PubMed ID: 3791245
[TBL] [Abstract][Full Text] [Related]
12. Immunochemical, 32P-postlabeling, and GC/MS detection of 4-aminobiphenyl-DNA adducts in human peripheral lung in relation to metabolic activation pathways involving pulmonary N-oxidation, conjugation, and peroxidation.
Culp SJ; Roberts DW; Talaska G; Lang NP; Fu PP; Lay JO; Teitel CH; Snawder JE; Von Tungeln LS; Kadlubar FF
Mutat Res; 1997 Aug; 378(1-2):97-112. PubMed ID: 9288889
[TBL] [Abstract][Full Text] [Related]
13. Analysis of DNA adducts in smokers' lung and urothelium by 32P-postlabelling: metabolic phenotype dependence and comparisons with other exposure markers.
Bartsch H; Castegnaro M; Camus AM; Schouft A; Geneste O; Rojas M; Alexandrov K
IARC Sci Publ; 1993; (124):331-40. PubMed ID: 8225503
[TBL] [Abstract][Full Text] [Related]
14. 4-Aminobiphenyl-hemoglobin adducts and risk of smoking-related disease in never smokers and former smokers in the European Prospective Investigation into Cancer and Nutrition prospective study.
Airoldi L; Vineis P; Colombi A; Olgiati L; Dell'Osta C; Fanelli R; Manzi L; Veglia F; Autrup H; Dunning A; Garte S; Hainaut P; Hoek G; Krzyzanowski M; Malaveille C; Matullo G; Overvad K; Tjonneland A; Clavel-Chapelon F; Linseisen J; Boeing H; Trichopoulou A; Palli D; Peluso M; Krogh V; Tumino R; Panico S; Bueno-De-Mesquita HB; Peeters PH; Lund E; Agudo A; Martinez C; Dorronsoro M; Barricarte A; Chirlaque MD; Quiros JR; Berglund G; Järvholm B; Hallmans G; Day NE; Allen N; Saracci R; Kaaks R; Riboli E
Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2118-24. PubMed ID: 16172219
[TBL] [Abstract][Full Text] [Related]
15. Carotenoids/vitamin C and smoking-related bladder cancer.
Castelao JE; Yuan JM; Gago-Dominguez M; Skipper PL; Tannenbaum SR; Chan KK; Watson MA; Bell DA; Coetzee GA; Ross RK; Yu MC
Int J Cancer; 2004 Jun; 110(3):417-23. PubMed ID: 15095308
[TBL] [Abstract][Full Text] [Related]
16. Relationship between environmental tobacco smoke exposure and carcinogen-hemoglobin adduct levels in nonsmokers.
Hammond SK; Coghlin J; Gann PH; Paul M; Taghizadeh K; Skipper PL; Tannenbaum SR
J Natl Cancer Inst; 1993 Mar; 85(6):474-8. PubMed ID: 8445675
[TBL] [Abstract][Full Text] [Related]
17. Urinary tobacco-specific nitrosamines and 4-aminobiphenyl hemoglobin adducts measured in smokers of either regular or light cigarettes.
Bernert JT; Jain RB; Pirkle JL; Wang L; Miller BB; Sampson EJ
Nicotine Tob Res; 2005 Oct; 7(5):729-38. PubMed ID: 16191744
[TBL] [Abstract][Full Text] [Related]
18. Acetylator phenotype, aminobiphenyl-hemoglobin adduct levels, and bladder cancer risk in white, black, and Asian men in Los Angeles, California.
Yu MC; Skipper PL; Taghizadeh K; Tannenbaum SR; Chan KK; Henderson BE; Ross RK
J Natl Cancer Inst; 1994 May; 86(9):712-6. PubMed ID: 8158701
[TBL] [Abstract][Full Text] [Related]
19. Decline of DNA damage and other biomarkers in peripheral blood following smoking cessation.
Mooney LA; Santella RM; Covey L; Jeffrey AM; Bigbee W; Randall MC; Cooper TB; Ottman R; Tsai WY; Wazneh L
Cancer Epidemiol Biomarkers Prev; 1995 Sep; 4(6):627-34. PubMed ID: 8547829
[TBL] [Abstract][Full Text] [Related]
20. Exposure levels and cytochrome P450 1A2 activity, but not N-acetyltransferase, glutathione S-transferase (GST) M1 and T1, influence urinary mutagen excretion in smokers.
Pavanello S; Simioli P; Lupi S; Gregorio P; Clonfero E
Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):998-1003. PubMed ID: 12376499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]